SAR245409 (XL765, Voxtalisib)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | SAR245409 is a PI3K/mTOR dual kinase inhibitor XL765 is an orally bioavailable small molecule targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinases in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. | ||
---|---|---|---|
Targets |
|
Catalog Num | A16276 |
---|---|
Formula | C13H14N6O |
Molecular Weight | 270.29 |
CAS Number | 934493-76-2 |
SMILES | O=C1C(C2=NNC=C2)=CC3=C(C)N=C(N)N=C3N1CC |
Synonyms | Voxtalisib, XL765, SAR 245409, SAR-245409, XL 765, XL-765 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 53 mg/mL (196.08 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 37 mL | 184.99 mL | 369.97 mL |
0.5 mM | 7.4 mL | 37 mL | 73.99 mL |
1 mM | 3.7 mL | 18.5 mL | 37 mL |
5 mM | 0.74 mL | 3.7 mL | 7.4 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2